Company Valuation: AsiaMedic Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 22.39 17.91 13.43 15.01 12.7 19.2
Change - -20% -25% 11.72% -15.38% 51.2%
Enterprise Value (EV) 1 18.29 13.89 12.13 14.86 22.37 27.38
Change - -24.04% -12.68% 22.48% 50.6% 22.38%
P/E -5.09x 26.7x 6.15x 7.67x 12.7x 9.72x
PBR 2.79x 2.05x 1.23x 1.13x 0.89x 1.2x
PEG - -0x 0x -0.6x -0.3x 0x
Capitalization / Revenue 1.46x 0.97x 0.71x 0.63x 0.44x 0.54x
EV / Revenue 1.19x 0.75x 0.64x 0.63x 0.77x 0.78x
EV / EBITDA -19.4x 11.9x 10.2x 9.28x 16.7x 17.6x
EV / EBIT -8.53x 17.5x 13.1x 20.6x 34.7x 41.1x
EV / FCF 14.6x 7.51x -31.8x 16.1x 21.5x -14.3x
FCF Yield 6.87% 13.3% -3.14% 6.2% 4.66% -6.99%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.003927 0.000599 0.001952 0.001696 0.000869 0.001749
Distribution rate - - - - - -
Net sales 1 15.38 18.42 19.04 23.75 29.09 35.29
EBITDA 1 -0.9441 1.17 1.189 1.6 1.336 1.56
EBIT 1 -2.144 0.7946 0.924 0.7197 0.6453 0.6667
Net income 1 -4.295 0.715 2.186 1.921 1.01 2.024
Net Debt 1 -4.105 -4.023 -1.305 -0.1524 9.675 8.18
Reference price 2 0.0200 0.0160 0.0120 0.0130 0.0110 0.0170
Nbr of stocks (in thousands) 1,119,522 1,119,522 1,119,522 1,154,522 1,154,522 1,129,522
Announcement Date 4/6/21 4/6/22 4/13/23 4/11/24 4/1/25 4/13/26
1SGD in Million2SGD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 19.57M
17.19x0.47x10.22x2.47% 137B
12.79x1.69x8.39x0.82% 84.78B
13.06x1.48x8.95x2.6% 28.09B
22.5x2.51x12.75x1.45% 25.15B
7.27x1.37x6.35x-.--% 20.09B
30.06x5.69x23.72x2.26% 20.74B
16.1x1.84x8.83x0.71% 15.12B
14.85x1.41x7.17x5.05% 14.49B
14.61x1.05x5.93x3.23% 13.07B
Average 16.49x 1.94x 10.26x 2.07% 35.9B
Weighted average by Cap. 16.15x 1.45x 10.09x 1.93%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 505 Stock
  4. Valuation AsiaMedic Limited